Loic Belle
Research Subjects
Loic Belle has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
Lionel Mangin
Cardiac Catheterization Laboratory, Regional Hospital Annecy-Genevois, Annecy, France
5 shared publicationsC. Ricard
Reseau Nord-Alpin des urgences, hospital, Annecy, France
4 shared publications- François-Xavier Ageron
Emergency Department, Lausanne University Hospital, Lausanne, Switzerland
4 shared publications - Guillaume Debaty
Univ. Grenoble Alpes, Emergency Department and Mobile Intensive Care Unit, CNRS, UMR 5525, Grenoble INP, TIMC, 38000 Grenoble, France
4 shared publications Hend Madiot
4 shared publications- José Labarère
University Grenoble Alps/CNRS/CHU de Grenoble Alpes/TIMC-IMAG UMR 5525, Grenoble, France
4 shared publications
Latest Publications
- Open Access
- 1 April 2022
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 12 (2) , 220-228
Safety of conservative management for non-stenotic culprit lesions in STEMI patients treated with a two-step reperfusion strategy: a SUPER-MIMI sub-study
Safety of conservative management for non-stenotic culprit lesions in STEMI patients treated with a two-step reperfusion strategy: a SUPER-MIMI sub-study Marc Bonnet, Stephanie Marliere, Victor Mathieu, Allan Tronchi, Nicolas Delarche, Mohamed Abdellaoui, Olivier Dubreuil, Ziad Boueri, Mohamed Chetibi, Geraud Souteyrand, Chloé Durier, Frederic Bouisset, Loic Belle
- 1 April 2022
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 12 (2) , 220-228
Open AccessSafety of conservative management for non-stenotic culprit lesions in STEMI patients treated with a two-step reperfusion strategy: a SUPER-MIMI sub-study
Safety of conservative management for non-stenotic culprit lesions in STEMI patients treated with a two-step reperfusion strategy: a SUPER-MIMI sub-study Marc Bonnet, Stephanie Marliere, Victor Mathieu, Allan Tronchi, Nicolas Delarche, Mohamed Abdellaoui, Olivier Dubreuil, Ziad Boueri, Mohamed Chetibi, Geraud Souteyrand, Chloé Durier, Frederic Bouisset, Loic Belle
- 23 January 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (2) , 411-412
Reply to “what have we learnt from the use of Papyrus covered stent in France and Spain?”
- 23 January 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (2) , 411-412
Reply to “what have we learnt from the use of Papyrus covered stent in France and Spain?”
- 21 October 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (5) , 874-881
Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry
Objectives: To evaluate the rate of procedural success and long‐term outcomes of the PK Papyrus (PKP) covered stent (CS).Background: CS are essential in the treatment of coronary artery perforation (CAP). They have also been used to treat coronary artery aneurysms. Limited evidence is available on clinical outcomes with the PKP.Methods: This was a multicenter, observational, retrospective, and prospective study. Consecutive patients undergoing intentional PKP implantation in 22 centers in France were included. The primary endpoint was the rate of procedural success. Secondary endpoints included rates of death, myocardial infarction (MI), target lesion revascularization (TLR), in‐stent restenosis (ISR), and stent thrombosis (ST).Results: Data from 130 patients were analyzed (mean age 72.5 ± 10.5 years; 71% men). The main indication for PKP was CAP, in 84 patients (65%). Delivery success was achieved in 95% and procedural success in 91%. During the in‐hospital stay, 15 patients died (12%) and 7 (5%) presented with ST. Data from 127 patients were available at 19.2 ± 12.8 month follow‐up. Thirty‐three patients died (26%), 15 (12%) had an MI and 21 (17%) presented with TLR. TLR was due to ISR in 12 patients (9%), 10 had definite ST (8%) and 1 patient for stent under‐expansion.Conclusions: The principal indication for PKP was CAP. PKP had high rates of delivery and procedural success. At long‐term follow‐up, there was a high rate of TLR, mainly due to ISR and ST. These results are consistent with previously reported data in these clinical settings.
- 21 October 2020
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (5) , 874-881
Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry
Objectives: To evaluate the rate of procedural success and long‐term outcomes of the PK Papyrus (PKP) covered stent (CS).Background: CS are essential in the treatment of coronary artery perforation (CAP). They have also been used to treat coronary artery aneurysms. Limited evidence is available on clinical outcomes with the PKP.Methods: This was a multicenter, observational, retrospective, and prospective study. Consecutive patients undergoing intentional PKP implantation in 22 centers in France were included. The primary endpoint was the rate of procedural success. Secondary endpoints included rates of death, myocardial infarction (MI), target lesion revascularization (TLR), in‐stent restenosis (ISR), and stent thrombosis (ST).Results: Data from 130 patients were analyzed (mean age 72.5 ± 10.5 years; 71% men). The main indication for PKP was CAP, in 84 patients (65%). Delivery success was achieved in 95% and procedural success in 91%. During the in‐hospital stay, 15 patients died (12%) and 7 (5%) presented with ST. Data from 127 patients were available at 19.2 ± 12.8 month follow‐up. Thirty‐three patients died (26%), 15 (12%) had an MI and 21 (17%) presented with TLR. TLR was due to ISR in 12 patients (9%), 10 had definite ST (8%) and 1 patient for stent under‐expansion.Conclusions: The principal indication for PKP was CAP. PKP had high rates of delivery and procedural success. At long‐term follow‐up, there was a high rate of TLR, mainly due to ISR and ST. These results are consistent with previously reported data in these clinical settings.
- 1 November 2019
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 68 (5) , 285-292
Quality of acute heart failure treatment in France: Data from REseau Nord-Alpin des Urgences (RENAU)
- 1 November 2019
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 68 (5) , 285-292
Quality of acute heart failure treatment in France: Data from REseau Nord-Alpin des Urgences (RENAU)
- Open Access
- 28 October 2019
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 19 (1) , 1-10
Early inter-hospital transfer of patients with myocardial infarction without a doctor, paramedic or nurse on board: results from a French regional emergency care network
Background: In France, patients with acute coronary syndromes (ACS) are usually transferred from remote hospitals to percutaneous coronary intervention (PCI) centres in mobile intensive care units (MICUs) with on-board medical staff. They are then returned to the remote hospitals by MICU 48 h after PCI. However, MICU transportation and beds in a PCI centre are in short supply. Therefore, we investigated clinical outcomes among intermediate-risk ACS patients who were transferred in private ambulances without an on-board medic or paramedic; and returned to the remote hospital sooner after PCI. Methods: In the French Alps, the RESURCOR network manages ‘SCA-Alp’ transfers using strict management protocols in ambulances with trained drivers and automatic external defibrillators, but without heart rhythm monitoring. We conducted an observational retrospective study that assessed outcomes (death and emergency return to the PCI centre within 48 h) in patients transferred using SCA-Alp. Our population comprised stabilized patients with ST-segment elevation myocardial infarction (STEMI) who returned to the remote hospital within 24–48 h of PCI, and uncomplicated patients with non-ST-segment elevation myocardial infarction (NSTEMI) within 24–72 h of symptom onset who come from and returned to (‘round-trip’) the remote hospital on the day of PCI (return < 12 h after PCI). Results: Between 2010 and 2014, 101 STEMI and 490 NSTEMI patients were transferred using SCA-Alp. No adverse events occurred during transportation and no deaths were reported. Two of 591 patients (0.3% [95% confidence interval 0.1–1.4%]) experienced a stent thrombosis within 48 h of PCI that required a second urgent PCI; both were event free at 6-month follow-up. Conclusions: Inter-hospital transfer using SCA-Alp is associated with low event rates in intermediate-risk ACS patients, allowing a more streamlined use of medical facilities and freeing-up of beds in PCI centres.
- 28 October 2019
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 19 (1) , 1-10
Open AccessEarly inter-hospital transfer of patients with myocardial infarction without a doctor, paramedic or nurse on board: results from a French regional emergency care network
Background: In France, patients with acute coronary syndromes (ACS) are usually transferred from remote hospitals to percutaneous coronary intervention (PCI) centres in mobile intensive care units (MICUs) with on-board medical staff. They are then returned to the remote hospitals by MICU 48 h after PCI. However, MICU transportation and beds in a PCI centre are in short supply. Therefore, we investigated clinical outcomes among intermediate-risk ACS patients who were transferred in private ambulances without an on-board medic or paramedic; and returned to the remote hospital sooner after PCI. Methods: In the French Alps, the RESURCOR network manages ‘SCA-Alp’ transfers using strict management protocols in ambulances with trained drivers and automatic external defibrillators, but without heart rhythm monitoring. We conducted an observational retrospective study that assessed outcomes (death and emergency return to the PCI centre within 48 h) in patients transferred using SCA-Alp. Our population comprised stabilized patients with ST-segment elevation myocardial infarction (STEMI) who returned to the remote hospital within 24–48 h of PCI, and uncomplicated patients with non-ST-segment elevation myocardial infarction (NSTEMI) within 24–72 h of symptom onset who come from and returned to (‘round-trip’) the remote hospital on the day of PCI (return < 12 h after PCI). Results: Between 2010 and 2014, 101 STEMI and 490 NSTEMI patients were transferred using SCA-Alp. No adverse events occurred during transportation and no deaths were reported. Two of 591 patients (0.3% [95% confidence interval 0.1–1.4%]) experienced a stent thrombosis within 48 h of PCI that required a second urgent PCI; both were event free at 6-month follow-up. Conclusions: Inter-hospital transfer using SCA-Alp is associated with low event rates in intermediate-risk ACS patients, allowing a more streamlined use of medical facilities and freeing-up of beds in PCI centres.
- 18 September 2019
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 68 (5) , 293-299
Évaluation de l’incidence des lésions de radiodermite en cardiologie interventionnelle
- 18 September 2019
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 68 (5) , 293-299
Évaluation de l’incidence des lésions de radiodermite en cardiologie interventionnelle
- 1 July 2017
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 13 (4) , 390-396
At least seven days delayed stenting using minimalist immediate mechanical intervention (MIMI) in ST-segment elevation myocardial infarction: the SUPER-MIMI study
The aim of this study was to ascertain whether a minimalist immediate mechanical intervention (MIMI) aiming to restore an optimal Thrombolysis In Myocardial Infarction (TIMI) flow in the culprit artery, followed ≥7 days later by a second percutaneous coronary intervention with intentional stenting, is safe in patients with ST-segment elevation myocardial infarction and large thrombotic burden. SUPER-MIMI was a prospective, observational trial conducted between January 2014 and April 2015 in 14 French centres. A total of 155 patients were enrolled. The pharmacological therapy was left to the operator's discretion. Eighty-one patients (52.3%) had glycoprotein IIb/IIIa inhibitors (GPI) initiated before the end of the first procedure. The median (interquartile range [IQR]) delay between the two procedures was eight (seven to 12) days. Infarct-related artery reocclusion between the two procedures (primary endpoint) occurred in two patients (1.3%), neither of whom received GPI treatment. TIMI flow was maintained or improved between the end of the first procedure and the beginning of the second procedure in all patients. Thrombotic burden and stenosis severity diminished significantly between the two procedures. Stents were ultimately implanted in 97 patients (62.6%). Deferred stenting (≥7 days) in patients with a high thrombus burden was safe on a background of GPI therapy.
- 1 July 2017
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 13 (4) , 390-396
At least seven days delayed stenting using minimalist immediate mechanical intervention (MIMI) in ST-segment elevation myocardial infarction: the SUPER-MIMI study
The aim of this study was to ascertain whether a minimalist immediate mechanical intervention (MIMI) aiming to restore an optimal Thrombolysis In Myocardial Infarction (TIMI) flow in the culprit artery, followed ≥7 days later by a second percutaneous coronary intervention with intentional stenting, is safe in patients with ST-segment elevation myocardial infarction and large thrombotic burden. SUPER-MIMI was a prospective, observational trial conducted between January 2014 and April 2015 in 14 French centres. A total of 155 patients were enrolled. The pharmacological therapy was left to the operator's discretion. Eighty-one patients (52.3%) had glycoprotein IIb/IIIa inhibitors (GPI) initiated before the end of the first procedure. The median (interquartile range [IQR]) delay between the two procedures was eight (seven to 12) days. Infarct-related artery reocclusion between the two procedures (primary endpoint) occurred in two patients (1.3%), neither of whom received GPI treatment. TIMI flow was maintained or improved between the end of the first procedure and the beginning of the second procedure in all patients. Thrombotic burden and stenosis severity diminished significantly between the two procedures. Stents were ultimately implanted in 97 patients (62.6%). Deferred stenting (≥7 days) in patients with a high thrombus burden was safe on a background of GPI therapy.
- 1 June 2017
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 7 (3) , 340-344
Unexpected evolution of a non-stenotic lesion in the left main coronary artery of a patient with non–ST-segment elevation myocardial infarction
A 72-year-old man was referred to our catheterization laboratory 48 hours after a non–ST-segment elevation myocardial infarction. His medical history included coronary artery disease (CAD) (percutaneous coronary intervention of the right coronary artery and chronic total occlusion of the circumflex artery), atrial fibrillation (AF), and chronic kidney disease. An electrocardiogram showed a pre-existent left bundle-branch block and the patient’s maximum cardiac troponin concentration was 8.64 µg/L (upper limit of normal: 0.003 µg/L). The coronary angiogram revealed an ulcerated plaque of the left main coronary artery (LMCA) and moderate stenosis of the left anterior descending (LAD) coronary artery. A non-interventional approach to treatment was chosen. One month later, a control angiography showed a giant distal aneurysm complicating the lesion; the fractional flow reserve (FFR) value in the LAD was 0.74. The heart team discussed the case and concluded that the aneurysm was inaccessible via surgery. To protect the LAD from possible covered stent thrombosis or restenosis, coronary artery bypass grafting of the LAD was performed prior to percutaneous coronary intervention (PCI). Five days later, we proceeded with percutaneous exclusion of the aneurysm. We combined coil embolization of three Interlock™ two-dimensional detachable coils with stenting of the LMCA, using a PK Papyrus™ covered stent. Effective angiographic exclusion was achieved. The patient was discharged on warfarin, aspirin, and clopidogrel for 1 month, followed by long-term aspirin and oral anticoagulation. A 6-month follow-up angiography demonstrated a completely sealed aneurysm and optical coherence tomography (OCT) confirmed the successful endothelialization of the covered stent.
- 1 June 2017
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 7 (3) , 340-344
Unexpected evolution of a non-stenotic lesion in the left main coronary artery of a patient with non–ST-segment elevation myocardial infarction
A 72-year-old man was referred to our catheterization laboratory 48 hours after a non–ST-segment elevation myocardial infarction. His medical history included coronary artery disease (CAD) (percutaneous coronary intervention of the right coronary artery and chronic total occlusion of the circumflex artery), atrial fibrillation (AF), and chronic kidney disease. An electrocardiogram showed a pre-existent left bundle-branch block and the patient’s maximum cardiac troponin concentration was 8.64 µg/L (upper limit of normal: 0.003 µg/L). The coronary angiogram revealed an ulcerated plaque of the left main coronary artery (LMCA) and moderate stenosis of the left anterior descending (LAD) coronary artery. A non-interventional approach to treatment was chosen. One month later, a control angiography showed a giant distal aneurysm complicating the lesion; the fractional flow reserve (FFR) value in the LAD was 0.74. The heart team discussed the case and concluded that the aneurysm was inaccessible via surgery. To protect the LAD from possible covered stent thrombosis or restenosis, coronary artery bypass grafting of the LAD was performed prior to percutaneous coronary intervention (PCI). Five days later, we proceeded with percutaneous exclusion of the aneurysm. We combined coil embolization of three Interlock™ two-dimensional detachable coils with stenting of the LMCA, using a PK Papyrus™ covered stent. Effective angiographic exclusion was achieved. The patient was discharged on warfarin, aspirin, and clopidogrel for 1 month, followed by long-term aspirin and oral anticoagulation. A 6-month follow-up angiography demonstrated a completely sealed aneurysm and optical coherence tomography (OCT) confirmed the successful endothelialization of the covered stent.
- 1 November 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (5) , 379
Treatment of acute cardiac failure in the emergency department. Improve our practices? Data from the RESURCOR network
- 1 November 2016
- Published by Elsevier in Annales de Cardiologie et d'Angéiologie
- Vol. 65 (5) , 379
Treatment of acute cardiac failure in the emergency department. Improve our practices? Data from the RESURCOR network